Dr Susanne Hodgson

Dr Susanne Hodgson (nee Sheehy)

I am a Research Fellow and Lecturer in Clinical Medicine responsible for organizing and delivering clinical teaching for medical students at St Peter’s College. Clinically, I work as physician specialising in Infectious Diseases and Microbiology based at the Oxford University Hospitals. I am also a Wellcome Trust Clinical Research Fellow based at the Jenner Institute, University of Oxford where my work focuses on the use of the Controlled Human Malaria Infection Model to improve understanding of immune responses to malaria.


At St Peter’s, I teach clinical skills to both undergraduate and graduate entry students and provide pastoral support. I have recently completed a Postgraduate Diploma in Learning and Teaching in Higher Education at the University of Oxford.


I joined the Jenner Institute, University of Oxford in 2009 as lead clinician on the blood-stage malaria vaccine program (www. Jenner.ac.uk/blood-stage). I then developed an interested in controlled human malaria infection (CHMI) studies and led CHMI trials in Oxford using blood-stage parasites, mosquito bite and cryopreserved sporozoites. My current research interest is the use of the CHMI model to understand natural immunity to malaria and validate novel functional assays of blood-stage immunity. I split my time between the Jenner Institute and the Kenyan Medical Research Institute where I am assisting with the set-up of the first CHMI centre in Kenya.

Selected Publications

Sheehy SH, Douglas AD, Draper SJ. Challenges of Assessing the Efficacy of Asexual Blood-Stage Plasmodium falciparum Malaria Vaccines. Hum Vaccin Immunother. 2013 Jun 18;9(9).

Sheehy SH, Spencer AJ, Douglas AD, Sim BKL, Longley RJ, Edwards NJ, Poulton ID, Kimani D, Williams AR, Anagnostou NA, Roberts R, Kerridge S, Voysey M, James ER, Billingsley PF, Gunasekera A, Lawrie AM, Hoffman SL and Hill AVS. Optimising Controlled Human Malaria Infection studies using cryopreserved P. falciparum Parasites administered by needle and syringe. PLoS One. 2013 Jun 18;8(6):e65960.

Sheehy SH, Duncan CJ, Elias SC, Choudhary P, Biswas S, Halstead FD, Collins KA, Edwards NJ, Douglas AD, Anagnostou NA, Ewer KJ, Havelock T, Mahungu T, Bliss CM, Miura K, Poulton ID, Lillie PJ, Antrobus RD, Berrie E, Moyle S, Gantlett K, Colloca S, Cortese R, Long CA, Sinden RE, Gilbert SC, Lawrie AM, Doherty T, Faust SN, Nicosia A, Hill AVS and Draper SJ. ChAd63-MVA Vectored Blood-Stage Malaria Vaccines Targeting MSP1 & AMA1: Assessment of Efficacy against Mosquito-Bite Challenge in Humans. Mol Ther. 2012 Dec;20(12):2355-68

Sheehy SH, Angus BJ. Malaria: severe, life threatening. Clin Evid (Online). 2011 Mar 7;2011. pii: 0913.